OSF Ventures is the corporate venture arm of OSF Healthcare, a major US health system. It invests in post-seed and Series A/B healthcare companies and offers something many financial VCs cannot: direct access to a health system environment for pilots, validation, and deployment. That makes it particularly valuable for companies with real-world clinical workflow relevance.

Its investment activity spans health IT, devices, therapeutics, diagnostics, and tech-enabled care delivery. For neurotech, the most important aspect is the connection to clinical adoption pathways, especially for products that need hospital integration, physician use, or system-level validation. The value of OSF Ventures lies as much in access and implementation support as in capital itself.

The fund focuses primarily on the United States. For neurotech founders, it is especially relevant for medical devices, digital neurology platforms, and care-delivery innovations that benefit from clinical pilots and health system adoption. It is a strong strategic investor where operational deployment matters early.